Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Apexigen Inc (APGN)

Apexigen Inc (APGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVID, CPRI, APGN PR Newswire - Fri Aug 11, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

APGN : 0.3851 (+8.48%)
CPRI : 21.64 (+1.36%)
AVID : 27.04 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VECT, RTL, APGN PR Newswire - Thu Jun 1, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

VECT : 16.85 (unch)
APGN : 0.3851 (+8.48%)
RTL : 7.61 (+1.06%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GNL, RTL, APGN PR Newswire - Wed May 24, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

GNL : 9.65 (+0.21%)
APGN : 0.3851 (+8.48%)
RTL : 7.61 (+1.06%)
Shareholder Alert: Ademi LLP investigates whether Apexigen, Inc. has obtained a Fair Price in its transaction with Pyxis Oncology PR Newswire - Wed May 24, 2023

/PRNewswire/ -- Ademi LLP is investigating Apexigen (Nasdaq: APGN) for possible breaches of fiduciary duty and other violations of law in its transaction with...

APGN : 0.3851 (+8.48%)
Apexigen Stock Soars After Analyst Rating, Is It Time to Buy? MarketBeat - Mon Jan 9, 2023

Apexigen stock is soaring after a bullish analyst rating. This can frequently give penny stocks legitimacy, but only if the stock can hold these gains.

EFHTU : 10.10 (-1.99%)
APGN : 0.3851 (+8.48%)

Barchart Exclusives

This High-Yield Dividend King Has 56 Years of Raises and Wall Street Is Screaming ‘Buy’ Barchart - 1 minute ago
This 56-year Dividend King yields 6.3%, carries a Moderate Buy rating, and could offer steady income plus upside despite industry shifts. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot